Rallis India Limited, a subsidiary of Tata Chemicals, is planning a Capex of Rs. 250 crore in FY 2022-23.

Speaking at Q2 FY23 Earnings Conference Call, Subhra Gourisaria, Chief Financial Officer, Rallis India Limited said, "Our overall Capex for the year should be Rs. 250 crore, of which we have spent around Rs. 100 crore during the first half."

"We are undertaking requisite steps towards growing both our business, domestic and international, new product launches, local sourcing of raw materials, scaling up of capacities, and wider distribution reach positions us well to grow our business and improve overall profitability going forward," added Gourisaria.

About commissioning of the new plant, Sanjiv Lal, Managing Director & Chief Executive Officer, Rallis India Limited said, "We'll be commissioning our new MPP plant this year towards Q4. So we expect the revenue streams to start from FY '24."

Rallis, a subsidiary of Tata Chemicals, has established a reputation of being a trusted solutions provider for agri-inputs, globally, with an emphasis on innovation, a thorough knowledge of farm science and a penetrative distribution network.

Rallis boasts of a robust product portfolio offering comprehensive crop care solutions, including formulations for crop protection and nutrition. It manufactures and markets a range of agri-inputs, which include pesticides, fungicides, insecticides, seeds, and plant growth nutrients. The product portfolio under each category covers a broad spectrum of crop-related requirements.